REG - Serco Group PLC - Serco wins CMS rebid valued at $690m

SercoAnnouncement

23/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230223:nRSW7715Qa&default-theme=true

RNS Number : 7715Q  Serco Group PLC  23 February 2023

Serco wins CMS rebid valued at $690m

 

23 February 2023

 

Serco has been awarded a contract by the US Department of Health and Human
Services, Centers for Medicare & Medicaid Services (CMS) to continue to
support eligibility determinations for citizens purchasing health insurance
through the Federal Health Insurance Exchanges.  The 4 year and 7-month
contract has a one-year base period and four option periods, and is due to
start on 1 July 2023.  The estimated total value to Serco, subject to
workload volumes, is approximately $690 million if all option periods are
exercised.

 

CMS serves the public as a trusted partner and steward, dedicated to advancing
health equity, expanding coverage, and improving health outcomes, and now
oversees the health coverage of more than 150 million people.

 

Serco will assist qualified citizens to receive health insurance through the
Affordable Care Act by taking a unified approach to operational services,
customer support, data analytics, and program management, all aimed at
continuously optimising service delivery and program integrity.

 

Mark Irwin, Serco Group Chief Executive, said: 'We are grateful for the trust
CMS has placed in us to continue to deliver these vital eligibility services
building on the value-based relationship we have formed since commencing these
services in 2013. During this time, we have assisted tens of millions of
Americans on their health journey, and as an impact partner to CMS, we are
fully committed to continuous improvement in citizen experience and delivering
our case management expertise in support of the strategic goals of our
customer.'

 

 

 

This announcement contains inside information.

 

Ends

 

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or
email: paul.checketts@serco.com (mailto:paul.checketts@serco.com)

Marcus De Ville, Head of Media Relations; tel +44 (0) 7738 898 550 or email:
marcus.deville@serco.com (mailto:marcus.deville@serco.com)

 

About Serco

Serco is a leading provider of public services.  Our customers are
governments or others operating in the public sector.  We gain scale,
expertise and diversification by operating internationally across five sectors
and four geographies: Defence, Justice & Immigration, Transport, Health
and Citizen Services, delivered in UK & Europe, North America, Asia
Pacific and the Middle East.

 

More information can be found at www.serco.com (http://www.serco.com)

 

 

Forward looking statements

This announcement contains statements which are, or may be deemed to be,
"forward-looking statements" which are prospective in nature.  All statements
other than statements of historical fact are forward-looking statements.
Generally, words such as "expect", "anticipate", "may", "could", "should",
"will", "aspire", "aim", "plan", "target", "goal", "ambition", "intend" and
similar expressions identify forward looking-statements.  By their nature,
these forward-looking statements are subject to a number of known and unknown
risks, uncertainties and contingencies, and actual results and events could
differ materially from those currently being anticipated as reflected in such
statements.  Factors which may cause future outcomes to differ from those
foreseen or implied in forward-looking statements include, but are not limited
to: general economic conditions and business conditions in Serco's markets;
contracts awarded to Serco; customers' acceptance of Serco's products and
services; operational problems; the actions of competitors, trading partners,
creditors, rating agencies and others; the success or otherwise of partnering;
changes in laws and governmental regulations; regulatory or legal actions,
including the types of enforcement action pursued and the nature of remedies
sought or imposed; the receipt of relevant third party and/or regulatory
approvals; exchange rate fluctuations; the development and use of new
technology; changes in public expectations and other changes to business
conditions; wars and acts of terrorism; cyber-attacks; and pandemics,
epidemics or natural disasters.  Many of these factors are beyond Serco's
control or influence.  These forward-looking statements speak only as of the
date of this announcement and have not been audited or otherwise independently
verified.  Past performance should not be taken as an indication or guarantee
of future results and no representation or warranty, express or implied, is
made regarding future performance.  Except as required by any applicable law
or regulation, Serco expressly disclaims any obligation or undertaking to
release publicly any updates or revisions to any forward looking statements
contained in this announcement to reflect any change in Serco's expectations
or any change in events, conditions or circumstances on which any such
statement is based after the date of this announcement, or to keep current any
other information contained in this announcement.  Accordingly, undue
reliance should not be placed on the forward-looking statements.

 

LEI: 549300PT2CIHYN5GWJ21

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CNTUUURROSUUUUR